The Synthpop Beat

Phased rollout isn’t a compromise. It’s how responsible healthcare organizations turn new technology into something they can actually depend on. And if you’re insisting on it – that’s not fear. That’s leadership doing its job.

Aspiring toward the patient journey means asking different questions – even while still operating at the task level: Where do patients get stuck most often? What happens after this task completes? Who owns the handoff if something goes wrong? How would we even know if a patient stopped moving forward?

Funding will accelerate automation of administrative workflows across the entire patient journey using multi-agent AI, helping providers focus on patient care.

In healthcare, production AI is not defined by how advanced the technology is. It’s defined by this question: “Can this system run every day, inside real workflows, with clear ownership and predictable outcomes?”

If the last few years were about proving AI could exist in healthcare, the next few will be about making it dependable. That’s not a step backward. It’s how technology earns its place.

Healthcare doesn’t need more pilots that never graduate. It needs AI systems that are designed – from the start – to operate in the real world. The difference between experimentation and the new normal isn’t ambition or intelligence. It’s operational discipline. That discipline is what allows AI to stop being a project – and start becoming infrastructure.

AI is a tool, not the goal. We must obsess about delivering value to our patients and healthcare organizations first, and that means building more complete offerings worthy of trust. The future of healthcare AI will not be loud. It will be normal. A new normal.

The next chapter of AI in healthcare will be defined by who proves, patiently, even quietly, that AI can operate safely and reliably inside the system healthcare already has.

As we close out 2025 and head into the holiday season, we want to pause and say thank you!

Synthpop, Inc., the AI Healthcare company transforming how providers automate clinical and administrative workflows, today announced that the team behind airt has joined Synthpop to strengthen its AI engineering and product capabilities.

At Synthpop, our mission is rooted in expertise. We don’t just build AI-powered healthcare solutions — we build them for the real-world complexities of healthcare and enterprise operations. From day one, DME has been in our DNA — and for the past year, Chip Smith has been at the heart of it.

Walking into Capitol Hill, I could feel the weight of what we were there to do. This wasn’t just another conference or networking event — it was an urgent opportunity to represent the voices of patients, suppliers, and partners who make home-based care possible every day.

Medtrade 2025 was a conference to remember. The Synthpop team was on the ground, meeting with industry leaders, showcasing our AI-powered solutions, and contributing to critical discussions about the future of healthcare technology. Here are the Top 3 Takeaways and Trends to look out for in 2025.

According to an recent HME Newspoll, 96% of businesses anticipate staffing challenges in 2025. Rather than hiring to compensate for inefficiencies, companies can do more with their existing staff, leveraging AI as a support system.

Synthpop reveals its suite of Conversational AI administrative solutions to automate payor and patient phone calls during or after business hours. Synthpop’s team will be in Booth 1641 and at the forefront of Medtrade 2025 with three exciting sessions.

After a record-breaking month in September 2024, we’re excited to introduce Synthpop’s DME and IDTF customers to products built with Synthpop’s Composable Intelligence, a game-changing framework to streamlining healthcare.

The future is here, and it's being shaped by AI. From social media and entertainment to lectures at healthcare conferences, suddenly, AI is everywhere... So, what's changed? Why has AI in healthcare surged to the forefront so quickly? This blog shares some insights from my experience and a conversation with Stanford Professor and Synthpop's Co-Founder, Jan Jannink.

Synthpop stands out not just for its impressive AI solutions, but for the talented and diverse team of experts behind these innovations. Here’s a look at the people powering Synthpop. 

Synthpop announced a $5.6M seed round led by Peterson Ventures and defy.vc. The AI-Driven platform is serving multiple healthcare providers, including durable medical equipment (DME) providers and independent diagnostic testing facilities (IDTFs)

Understaffed? Seems like we all are.

Synthpop welcomes Chip Smith, who has over two decades of leadership and expertise in the DME industry,

Sustainability in healthcare depends on the development and adoption of Artificial Intelligence (AI) tools.

Synthpop recently welcomed Scott Holzberg as the VP of Sales.

Bonafide and Synthpop announced a strategic partnership during MedTrade 2024.

Synthpop debuts its cutting-edge AI solutions at MedTrade.

Synthpop is pleased to announce its recent product launch - a new connected system of AI assistants for Healthcare workflow automation.

An Innovative Approach to Patient Care with Enhanced Accuracy, and Privacy Protection